Literature DB >> 22969989

Tumor necrosis factor-α -308G/A polymorphism is associated with active vitiligo vulgaris in a northeastern Mexican population.

Mauricio Salinas-Santander1, Daniel Díaz-García, Augusto Rojas-Martínez, Cristina Cantú-Salinas, Celia Sánchez-Domínguez, Miguel Reyes-López, Ricardo M Cerda-Flores, Jorge Ocampo-Candiani, Rocío Ortiz-López.   

Abstract

Vitiligo is a skin disease characterized by depigmentation. Its etiopathogenesis is unclear, but it has been associated with autoimmune processes. Gene polymorphisms in the tumor necrosis factor-α (TNF-α) have been associated with several imflammatory diseases. In particular, the -308G/A polymorphism in the gene promoter region has been reported to be associated with increased plasma levels of TNF-α and with an increased risk to develop autoimmune diseases. To date, this polymorphism has not been associated with vitiligo. To assess a possible association between the TNF-α -308G/A and vitiligo vulgaris (VV), 198 vitiligo patients and 395 control subjects were recruited for the study. A complete demographic and clinical profile of each case was registered to analyze the possible risk factors of vitiligo. Genomic DNA isolated from peri pheral blood was subjected to PCR-RFLP for genotyping of the TNF-α -308G/A polymorphism. Causal associations were determined by χ(2) test and their respective OR was assessed in a 2×2 contingency table. When population variables of type of vitiligo, gender, age of disease onset, and active disease status were considered, an association between active VV and the TNF-α GA genotype was found (P=0.0295, OR=2.0; 95% CI 1.01-3.93). All other variables were irrelevant to vitiligo. Our data suggest a possible association between the TNF-α -308 GA genotype and the active form of VV in a Mexican population.

Entities:  

Year:  2012        PMID: 22969989      PMCID: PMC3438838          DOI: 10.3892/etm.2012.508

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  17 in total

Review 1.  A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy?

Authors:  Yvon Gauthier; Muriel Cario Andre; Alain Taïeb
Journal:  Pigment Cell Res       Date:  2003-08

2.  [A family history of vitiligo with autosomal dominant inheritance].

Authors:  Bi-Cai Zhu; Jian-Guo Gao; Ai Qu; Lin He; Xiu-Qin Wang; Zi-Feng Zhang; Yong Zhang; Jun-Fang Gao
Journal:  Yi Chuan       Date:  2002-05

Review 3.  Vitiligo: pathomechanisms and genetic polymorphism of susceptible genes.

Authors:  E M Shajil; Sreejata Chatterjee; Deepali Agrawal; T Bagchi; Rasheedunnisa Begum
Journal:  Indian J Exp Biol       Date:  2006-07       Impact factor: 0.818

4.  Genes for the tumor necrosis factors alpha and beta are linked to the human major histocompatibility complex.

Authors:  T Spies; C C Morton; S A Nedospasov; W Fiers; D Pious; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

5.  Impact of genetic variation of tumor necrosis factor-alpha on gestational hypertension.

Authors:  You-peng Chen; Thiemo Pfab; Torsten Slowinski; Claus-Michael Richter; Michael Godes; Berthold Hocher
Journal:  Chin Med J (Engl)       Date:  2006-05-05       Impact factor: 2.628

Review 6.  Vitiligo update.

Authors:  Rebat M Halder; Johnathan L Chappell
Journal:  Semin Cutan Med Surg       Date:  2009-06

7.  Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with rheumatic heart disease.

Authors:  Guadalupe Hernández-Pacheco; Carmina Flores-Domínguez; José Manuel Rodríguez-Pérez; Nonanzit Pérez-Hernández; José Manuel Fragoso; Angela Saul; Edith Alvarez-León; Julio Granados; Pedro A Reyes; Gilberto Vargas-Alarcón
Journal:  J Autoimmun       Date:  2003-08       Impact factor: 7.094

8.  Frequency of S and Z alleles for alpha-1-antitrypsin and tumor necrosis factor alpha -308 promoter polymorphism in northeastern Mexico.

Authors:  Celia Nohemí Sánchez-Domínguez; José Antonio Buenfil-Lozano; Carlos Alejandro Molina-Guajardo; Omar David Borjas-Almaguer; Abraham Castillo-Lartigue; Adriana Bustamante-Sáenz; Herminia Guadalupe Martínez-Rodríguez; Miguel Angel Villarreal Alarcón; Miguel Angel Reyes-López; Rocío Ortiz-López
Journal:  Allergy Asthma Proc       Date:  2008-06-04       Impact factor: 2.587

Review 9.  Tumor necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta).

Authors:  N H Ruddle
Journal:  Curr Opin Immunol       Date:  1992-06       Impact factor: 7.486

Review 10.  Vitiligo: a manifestation of apoptosis?

Authors:  Carol L Huang; James J Nordlund; Raymond Boissy
Journal:  Am J Clin Dermatol       Date:  2002       Impact factor: 7.403

View more
  4 in total

1.  Assessment of biochemical parameters and characterization of TNFα -308G/A and PTPN22 +1858C/T gene polymorphisms in the risk of obesity in adolescents.

Authors:  Mauricio Andrés Salinas-Santander; Rafael Baltazar León-Cachón; Ana Cecilia Cepeda-Nieto; Celia Nohemí Sánchez-Domínguez; María Antonia González-Zavala; Hugo Leonid Gallardo-Blanco; Sandra Cecilia Esparza-González; Miguel Ángel González-Madrazo
Journal:  Biomed Rep       Date:  2015-10-27

2.  Association between the CTLA4 +49A/G (rs231775) and CT60 (rs3087243) gene variants with vitiligo: study on a Mexican population.

Authors:  Mauricio Andrés Salinas-Santander; Víctor de Jesús Suárez-Valencia; Mayela Del Ángel-Martínez; David Emmanuel Kubelis-Lopez; Natalia Aranza Zapata-Salazar; Jorge Alejandro Ocampo-Garza; Jorge Ocampo-Candiani
Journal:  An Bras Dermatol       Date:  2022-09-24       Impact factor: 2.113

Review 3.  Novel immunological and genetic factors associated with vitiligo: A review.

Authors:  Salvador Luis Said-Fernandez; Celia Nohemi Sanchez-Domínguez; Mauricio Andres Salinas-Santander; Herminia Guadalupe Martinez-Rodriguez; David Emmanuel Kubelis-Lopez; Natalia Aranza Zapata-Salazar; Osvaldo Tomas Vazquez-Martinez; Uwe Wollina; Torello Lotti; Jorge Ocampo-Candiani
Journal:  Exp Ther Med       Date:  2021-02-01       Impact factor: 2.447

4.  Evaluation of the Efficacy of Topical Tetracycline in Enhancing the Effect of Narrow Band UVB against Vitiligo: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial.

Authors:  Amir Kalafi; Farideh Jowkar
Journal:  ISRN Dermatol       Date:  2014-02-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.